Recent Updates
Recently added Catalysts
TFX Positive Sentiment Score: 75/100

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

Key Takeaway: Teleflex Incorporated will hold a conference call on November 6, 2025, to discuss its third quarter financial results and provide operational updates. Additionally, a virtual meeting on November 14, 2025, will review the company's recent acquisition in the Vascular Intervention sector. Interested participants can pre-register for both events via the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Teleflex is hosting a conference call for Q3 financial results.
  • The company is providing operational updates to investors.
  • A virtual meeting will focus on a recent business acquisition.

Full Press Release Details

WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025.
To participate in the conference call, please utilize thislinkto pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website,teleflex.com.
An audio replay of the call will be available beginning at 11:00 am Eastern Time on November 6, 2025, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conference ID is 69028.

Vascular Intervention Virtual Meeting

On November 14, 2025, at 8:00 am Eastern Time, Teleflex will host a virtual meeting to review its recent Vascular Intervention business acquisition, with a focus on the strategic rationale and the comprehensive coronary and peripheral product portfolio.
To participate in the investor event, please utilize thislinkto pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website,teleflex.com.

About Teleflex Incorporated

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visitteleflex.com.

Contacts:Teleflex Incorporated:Lawrence KeuschVice President, Investor Relations and Strategy Development

investors.teleflex.com610-948-2836

Frequently Asked Questions

When is the Teleflex Q3 2025 earnings call?

The Teleflex Q3 2025 earnings call is scheduled for November 6, 2025, at 8:00 a.m. ET.

How can I access the Teleflex earnings call?

Participants can pre-register for the call or access it via a live audio webcast on teleflex.com.

What is the focus of the Vascular Intervention virtual meeting?

The virtual meeting on November 14, 2025, will review Teleflex's recent Vascular Intervention business acquisition.

Is there a replay available for the earnings call?

Yes, an audio replay will be available starting at 11:00 a.m. ET on November 6, 2025.

Last updated: Oct 16, 2025